Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Prostate Cancer Foundation of Chicago
Age
40–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed adenocarcinoma of the prostate, clinical stage T1c - T2b, N0, M0
Greater than or equal to 40 years of age
Low and Low- Intermediate Risk prostate cancer
Prostate volumes by TRUS ≤ 60 cc
I-PSS score \< 25 (alpha blockers allowed)
Signed study-specific informed consent form prior to study entry
You may not be if
Lymph node involvement (N1)
Evidence of distant metastases (M1)
Radical surgery for carcinoma of the prostate
Prior pelvic radiation
Major medical or psychiatric illness, which in the investigator's opinion would prevent completion of treatment and would interfere with follow- up or ability to complete questionnaires
Hip prosthesis
Inability or refusal to provide informed consent
Evidence of Previous TURP
Prior hormone therapy
Prior TURP
Clareo Health | Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy
